RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...

NCH has achieved a breakthrough with the first U.S. implantation of the WiSE CRT System combined with a leadless pacemaker, offering a new treatment option for heart failure patients.

In 2021 alone, the FDA ordered recalls on certain Medtronic and Abbott pacemakers and Medtronic defibrillators, owing to premature battery depletion. Another commercial reality is that major product ...

In 2021 alone, the FDA ordered recalls on certain Medtronic and Abbott pacemakers and Medtronic defibrillators, owing to premature battery depletion.

In 2021 alone, the FDA ordered recalls on certain Medtronic and Abbott pacemakers and Medtronic defibrillators, owing to premature battery depletion.

For more information about training, patient selection, or clinical support, please contact EBR at www.ebrsystemsinc.com. *Medtronic's Micra leadless pacemaker has been qualified for use with WiSE ...

Health Check: With the FDA’s approval, EBR is ready to revolutionise the heart failure device market The US Food & Drug Administration has approved EBR System’s leadless pacemaker WISE, the ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle stimulation.

Halloween 1957: How a widespread blackout put Medtronic on the map with the invention of the portable pacemaker The outage rendered life-saving pacemakers useless, and triggered innovation.